Le Lézard
Classified in: Health
Subjects: LBR, POL

Express Scripts' Accredo Earns Renewed URAC Specialty Pharmacy Accreditation


ST. LOUIS, Jan. 10, 2018 /PRNewswire/ -- Accredo® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), has earned URAC's specialty pharmacy accreditation at its primary dispensing locations: Warrendale, Pa., New Castle, Del., Indianapolis, Ind., Orlando, Fla., Memphis, Tenn., Greensboro, N.C., Nashville, Tenn., and Corona, Calif.

In addition, Express Scripts Freedom Fertility Pharmacy, located in Byfield, Mass., gained renewal of URAC's specialty pharmacy accreditation.

URAC is a Washington D.C.-based independent accreditor of health care management organizations. To earn its specialty pharmacy accreditation, pharmacies must pass rigorous performance measures, which include meeting accuracy and turnaround time of dispensed prescriptions, having policies and procedures that ensure adherence to drug safety protocols, and maintaining a patient-centered strategy for its patient management program.

"Our patients are at the center of everything we do, and we serve those with the most complex, chronic diseases," said Brian Seiz, president, Accredo. "We're proud to receive URAC accreditation and we're appreciative of its validation of the quality and value of the care provided by our team."

Specialized Patient Care

Accredo specialty pharmacies provide personalized patient care. Extensive patient education and proactive outreach help improve health outcomes while reducing healthcare costs.  Accredo's team of specialty clinicians include 500 specialist pharmacists and 550 field-based nurses located throughout the U.S.

Through its Therapeutic Resource Centers®, Accredo provides care for a variety of conditions including cancer, hepatitis C, transplant, bleeding disorders, autoimmune disease, and pulmonary arterial hypertension.

"It's necessary for specialty pharmacies to provide a higher of level of treatment for patients so desired outcomes are achieved. Accredo shows a dedication to patient education and safety through the recognition of quality it received with URAC's independent accreditation," said URAC President and CEO Kylanne Green. "With URAC accreditation, people know that Accredo strives to adhere to industry practices."

About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services.  Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

About URAC

Founded in 1990, URAC is the independent leader in advancing healthcare quality through leadership, accreditation, measurement and innovation. URAC offers a wide range of quality benchmarking programs that reflect the latest changes in healthcare and provide a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. URAC uses evidence-based measures and develops standards through inclusive engagement with a broad range of stakeholders committed to improving the quality of healthcare. For more information, visit urac.org

Media Contacts:

Christine Portell, Express Scripts
314-409-7990
[email protected]

 

SOURCE Express Scripts


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: